• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 16, 2023

    3/16/23 6:59:03 AM ET
    $SYPR
    $TG
    $TITN
    $TLS
    Industrial Machinery/Components
    Industrials
    Metal Fabrications
    Industrials
    Get the next $SYPR alert in real time by email

    Companies Reporting Before The Bell

    • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.

    • ImmunoPrecise Antibodies (NASDAQ:IPA) is projected to report quarterly loss at $0.17 per share on revenue of $3.96 million.

    • Blue Apron Hldgs (NYSE:APRN) is expected to report quarterly loss at $0.83 per share on revenue of $100.13 million.

    • Yiren Digital (NYSE:YRD) is estimated to report earnings for its second quarter.

    • KE Holdings (NYSE:BEKE) is likely to report quarterly earnings at $0.08 per share on revenue of $2.29 billion.

    • Hello Gr (NASDAQ:MOMO) is projected to report quarterly earnings at $0.29 per share on revenue of $465.30 million.

    • Children's Place (NASDAQ:PLCE) is likely to report quarterly loss at $4.09 per share on revenue of $455.33 million.

    • Sidus Space (NASDAQ:SIDU) is projected to report quarterly loss at $0.15 per share on revenue of $1.25 million.

    • WiSA Technologies (NASDAQ:WISA) is expected to report quarterly loss at $17.50 per share on revenue of $1.00 million.

    • Pyxis Tankers (NASDAQ:PXS) is estimated to report quarterly earnings at $0.46 per share on revenue of $16.06 million.

    • VEON (NASDAQ:VEON) is estimated to report earnings for its fourth quarter.

    • REE Automotive (NASDAQ:REE) is estimated to report quarterly loss at $0.11 per share on revenue of $950 thousand.

    • Sypris Solutions (NASDAQ:SYPR) is projected to report earnings for its fourth quarter.

    • Global X Guru Index ETF (NYSE:GURU) is projected to report quarterly loss at $0.10 per share on revenue of $6.01 million.

    • Tredegar (NYSE:TG) is projected to report earnings for its fourth quarter.

    • Titan Machinery (NASDAQ:TITN) is likely to report quarterly earnings at $1.13 per share on revenue of $684.35 million.

    • PureCycle Technologies (NASDAQ:PCT) is projected to report earnings for its fourth quarter.

    • Xunlei (NASDAQ:XNET) is estimated to report earnings for its fourth quarter.

    • Tsakos Energy Navigation (NYSE:TNP) is likely to report quarterly earnings at $3.10 per share on revenue of $225.00 million.

    • Academy Sports (NASDAQ:ASO) is likely to report quarterly earnings at $1.84 per share on revenue of $1.80 billion.

    • G-III Apparel Group (NASDAQ:GIII) is projected to report quarterly earnings at $0.45 per share on revenue of $770.72 million.

    • Provention Bio (NASDAQ:PRVB) is expected to report quarterly loss at $0.46 per share on revenue of $8.30 million.

    • Signet Jewelers (NYSE:SIG) is projected to report quarterly earnings at $5.38 per share on revenue of $2.65 billion.

    • Dollar Gen (NYSE:DG) is estimated to report quarterly earnings at $2.96 per share on revenue of $10.24 billion.

    • Designer Brands (NYSE:DBI) is estimated to report quarterly loss at $0.02 per share on revenue of $791.81 million.

    • Honest Co (NASDAQ:HNST) is projected to report quarterly loss at $0.05 per share on revenue of $80.37 million.

    • Williams-Sonoma (NYSE:WSM) is estimated to report quarterly earnings at $5.45 per share on revenue of $2.60 billion.

    • LENSAR (NASDAQ:LNSR) is likely to report quarterly loss at $0.25 per share on revenue of $10.00 million.

    • UroGen Pharma (NASDAQ:URGN) is likely to report quarterly loss at $1.07 per share on revenue of $18.51 million.

    • Iterum Therapeutics (NASDAQ:ITRM) is projected to report earnings for its fourth quarter.

    • Evelo Biosciences (NASDAQ:EVLO) is likely to report earnings for its fourth quarter.

    • Liquidia (NASDAQ:LQDA) is estimated to report quarterly loss at $0.15 per share on revenue of $3.55 million.

    • Telos (NASDAQ:TLS) is estimated to report earnings for its fourth quarter.

    • Paratek Pharmaceuticals (NASDAQ:PRTK) is likely to report quarterly earnings at $0.09 per share on revenue of $63.45 million.

    • AC Immune (NASDAQ:ACIU) is estimated to report quarterly loss at $0.26 per share on revenue of $1.71 million.

    • BK Technologies (AMEX:BKTI) is estimated to report quarterly earnings at $0.05 per share on revenue of $18.15 million.

    • Acurx Pharmaceuticals (NASDAQ:ACXP) is expected to report earnings for its fourth quarter.

    • Janus Intl Gr (NYSE:JBI) is likely to report quarterly earnings at $0.22 per share on revenue of $260.79 million.

    • Lizhi (NASDAQ:LIZI) is projected to report earnings for its fourth quarter.

    • Coda Octopus Group (NASDAQ:CODA) is projected to report quarterly earnings at $0.09 per share on revenue of $5.59 million.

    • Lands' End (NASDAQ:LE) is likely to report quarterly earnings at $0.06 per share on revenue of $518.45 million.

    • Acacia Research (NASDAQ:ACTG) is expected to report earnings for its fourth quarter.

    • American Strategic (NYSE:NYC) is expected to report earnings for its fourth quarter.

    • MediWound (NASDAQ:MDWD) is likely to report quarterly loss at $0.59 per share on revenue of $6.60 million.

    • Real Brokerage (NASDAQ:REAX) is likely to report quarterly loss at $0.03 per share on revenue of $88.15 million.

    • Jabil (NYSE:JBL) is projected to report quarterly earnings at $1.85 per share on revenue of $8.09 billion.

    • Prestige Consumer (NYSE:PBH) is expected to report quarterly earnings at $1.28 per share on revenue of $1.54 billion.

    • RumbleON (NASDAQ:RMBL) is likely to report quarterly loss at $0.14 per share on revenue of $398.55 million.

    • Destination XL Group (NASDAQ:DXLG) is estimated to report quarterly earnings at $0.10 per share on revenue of $144.44 million.

    • Apyx Medical (NASDAQ:APYX) is estimated to report quarterly loss at $0.14 per share on revenue of $12.94 million.

    • CENTRAL & EASTERN EUROPE (NYSE:CEE) is estimated to report earnings for its Fiscal Year 2022.

    • Aveanna Healthcare Hldgs (NASDAQ:AVAH) is expected to report quarterly loss at $0.02 per share on revenue of $448.16 million.

    • CION Invt (NYSE:CION) is projected to report quarterly earnings at $0.35 per share on revenue of $49.39 million.

    • Despegar.com (NYSE:DESP) is projected to report quarterly loss at $0.08 per share on revenue of $150.25 million.

    Companies Reporting After The Bell

    • Clipper Realty (NYSE:CLPR) is expected to report earnings for its fourth quarter.

    • Vitru (NASDAQ:VTRU) is estimated to report quarterly loss at $0.08 per share on revenue of $81.31 million.

    • Groupon (NASDAQ:GRPN) is expected to report quarterly loss at $0.40 per share on revenue of $161.55 million.

    • Akumin (NASDAQ:AKU) is expected to report earnings for its fourth quarter.

    • Karat Packaging (NASDAQ:KRT) is estimated to report quarterly earnings at $0.32 per share on revenue of $96.12 million.

    • HEXO (NASDAQ:HEXO) is estimated to report quarterly loss at $0.16 per share on revenue of $26.31 million.

    • Impac Mortgage Holdings (AMEX:IMH) is expected to report earnings for its fourth quarter.

    • Adamis Pharmaceuticals (NASDAQ:ADMP) is estimated to report earnings for its fourth quarter.

    • ATI Physical Therapy (NYSE:ATIP) is likely to report quarterly loss at $0.07 per share on revenue of $162.66 million.

    • Hallador Energy (NASDAQ:HNRG) is estimated to report earnings for its fourth quarter.

    • TOMI Environmental Solns (NASDAQ:TOMZ) is likely to report earnings for its fourth quarter.

    • Comstock (AMEX:LODE) is estimated to report quarterly loss at $0.05 per share on revenue of $40 thousand.

    • EzFill Holdings (NASDAQ:EZFL) is likely to report earnings for its fourth quarter.

    • Blend Labs (NYSE:BLND) is projected to report quarterly loss at $0.16 per share on revenue of $44.98 million.

    • Purple Innovation (NASDAQ:PRPL) is expected to report quarterly loss at $0.06 per share on revenue of $144.16 million.

    • HeartBeam (NASDAQ:BEAT) is projected to report earnings for its fourth quarter.

    • Arena Group Holdings (AMEX:AREN) is projected to report quarterly loss at $0.76 per share on revenue of $62.29 million.

    • Onconova Therapeutics (NASDAQ:ONTX) is projected to report quarterly loss at $0.28 per share on revenue of $60 thousand.

    • Geron (NASDAQ:GERN) is estimated to report quarterly loss at $0.12 per share on revenue of $120 thousand.

    • Trevi Therapeutics (NASDAQ:TRVI) is expected to report earnings for its fourth quarter.

    • CymaBay Therapeutics (NASDAQ:CBAY) is expected to report earnings for its fourth quarter.

    • Acutus Medical (NASDAQ:AFIB) is projected to report quarterly loss at $0.71 per share on revenue of $4.32 million.

    • BioLife Solns (NASDAQ:BLFS) is likely to report quarterly loss at $0.17 per share on revenue of $43.41 million.

    • Eastman Kodak (NYSE:KODK) is projected to report earnings for its fourth quarter.

    • Co-Diagnostics (NASDAQ:CODX) is likely to report quarterly loss at $0.15 per share on revenue of $5.50 million.

    • SenesTech (NASDAQ:SNES) is likely to report earnings for its fourth quarter.

    • Panbela Therapeutics (NASDAQ:PBLA) is estimated to report earnings for its fourth quarter.

    • Eton Pharmaceuticals (NASDAQ:ETON) is projected to report quarterly earnings at $0.01 per share on revenue of $9.12 million.

    • Sarcos Technology (NASDAQ:STRC) is expected to report quarterly loss at $0.15 per share on revenue of $5.70 million.

    • Netcapital (NASDAQ:NCPL) is estimated to report earnings for its third quarter.

    • HireQuest (NASDAQ:HQI) is estimated to report quarterly earnings at $0.28 per share on revenue of $8.80 million.

    • RiceBran Tech (NASDAQ:RIBT) is expected to report earnings for its fourth quarter.

    • Montauk Renewables (NASDAQ:MNTK) is estimated to report quarterly earnings at $0.09 per share on revenue of $57.32 million.

    • System1 (NYSE:SST) is expected to report quarterly loss at $0.37 per share on revenue of $185.46 million.

    • Achieve Life Sciences (NASDAQ:ACHV) is projected to report quarterly loss at $0.83 per share on revenue of $100 thousand.

    • PLBY Group (NASDAQ:PLBY) is projected to report quarterly loss at $0.17 per share on revenue of $75.56 million.

    • Microvast Holdings (NASDAQ:MVST) is projected to report quarterly loss at $0.15 per share on revenue of $60.50 million.

    • Traeger (NYSE:COOK) is projected to report quarterly loss at $0.15 per share on revenue of $118.31 million.

    • GoHealth (NASDAQ:GOCO) is estimated to report quarterly earnings at $1.33 per share on revenue of $358.04 million.

    • FedEx (NYSE:FDX) is estimated to report quarterly earnings at $2.73 per share on revenue of $22.76 billion.

    • WM Tech (NASDAQ:MAPS) is expected to report quarterly loss at $0.13 per share on revenue of $47.83 million.

    • Leafly Holdings (NASDAQ:LFLY) is projected to report quarterly loss at $0.18 per share on revenue of $12.12 million.

    • Meta Materials (NASDAQ:MMAT) is projected to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $SYPR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYPR
    $TG
    $TITN
    $TLS

    CompanyDatePrice TargetRatingAnalyst
    FedEx Corporation
    $FDX
    2/25/2026$335.00Hold → Reduce
    HSBC Securities
    Dollar General Corporation
    $DG
    2/17/2026$111.00Neutral → Sell
    Rothschild & Co Redburn
    FedEx Corporation
    $FDX
    2/13/2026$313.00 → $383.00Buy
    TD Cowen
    KE Holdings Inc
    $BEKE
    2/3/2026$19.00Buy → Neutral
    Goldman
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    FedEx Corporation
    $FDX
    2/3/2026$427.00Mkt Perform → Outperform
    Bernstein
    FedEx Corporation
    $FDX
    1/21/2026$271.00Buy → Neutral
    Rothschild & Co Redburn
    The Honest Company Inc.
    $HNST
    1/16/2026Overweight → Underweight
    Analyst
    More analyst ratings

    $SYPR
    $TG
    $TITN
    $TLS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXOBRID issued to MEDIWOUND, LTD

    Submission status for MEDIWOUND, LTD's drug NEXOBRID (SUPPL-10) with active ingredient ANACAULASE-BCDB has changed to 'Approval' on 08/15/2024. Application Category: BLA, Application Number: 761192, Application Classification:

    8/16/24 4:36:54 AM ET
    $MDWD
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for LIVDELZI issued to CYMABAY THERAPEUTICS INC

    Submission status for CYMABAY THERAPEUTICS INC's drug LIVDELZI (ORIG-1) with active ingredient SELADELPAR has changed to 'Approval' on 08/14/2024. Application Category: NDA, Application Number: 217899, Application Classification: Type 1 - New Molecular Entity

    8/14/24 12:53:53 PM ET
    $CBAY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Radoff Bradley Louis bought $187,944 worth of shares (30,000 units at $6.26), increasing direct ownership by 1% to 2,180,000 units (SEC Form 4)

    4 - KVH INDUSTRIES INC \DE\ (0001007587) (Issuer)

    2/12/26 5:56:05 PM ET
    $KVHI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $SYPR
    $TG
    $TITN
    $TLS
    SEC Filings

    View All

    Eastman Kodak Company Common New filed SEC Form 8-K: Leadership Update

    8-K - EASTMAN KODAK CO (0000031235) (Filer)

    2/27/26 5:00:27 PM ET
    $KODK
    Industrial Machinery/Components
    Consumer Discretionary

    Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

    2/27/26 4:30:28 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care

    Children's Place Inc. filed SEC Form 8-K: Leadership Update

    8-K - Childrens Place, Inc. (0001041859) (Filer)

    2/27/26 4:30:35 PM ET
    $PLCE
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    FedEx downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded FedEx from Hold to Reduce and set a new price target of $335.00

    2/25/26 11:18:50 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Dollar General downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Dollar General from Neutral to Sell and set a new price target of $111.00

    2/17/26 8:12:52 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    TD Cowen reiterated coverage on FedEx with a new price target

    TD Cowen reiterated coverage of FedEx with a rating of Buy and set a new price target of $383.00 from $313.00 previously

    2/13/26 8:02:23 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

    • EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology's Genitourinary Cancers Symposium (ASCO-GU 2026) PRINCETON, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative, non-surgical therapies for urothelial and specialty cancers, today announced new post-hoc analyses from the Phase 3 ENVISION trial showing that ZUSDURI™ (mitomycin) for intravesical solution (formerly known as UGN-102) achieved durable complete response (CR) rates across European Organization for Research and Treatment of Cancer (EORTC) recurrence score g

    2/27/26 8:30:00 AM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Montauk Renewables Schedules Full Year 2025 Conference Call for Thursday, March 12, 2026, at 8:30 a.m. ET

    PITTSBURGH, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas ("RNG"), will host a conference call and webcast on Thursday, March 12, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the day prior to the conference call and webcast. Full Year 2025 Conference Call and Webcast Details  Date:Thursday, March 12, 2026Time:8:30 a.m. ETPartici

    2/26/26 4:30:00 PM ET
    $MNTK
    Natural Gas Distribution
    Utilities

    $SYPR
    $TG
    $TITN
    $TLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robinson James A. Jr. converted options into 2,000 units of ordinary shares, increasing direct ownership by 100% to 4,000 units (SEC Form 4)

    4 - UroGen Pharma Ltd. (0001668243) (Issuer)

    2/27/26 4:44:12 PM ET
    $URGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Eastman Kodak Company Common New

    4 - EASTMAN KODAK CO (0000031235) (Issuer)

    2/26/26 9:15:33 PM ET
    $KODK
    Industrial Machinery/Components
    Consumer Discretionary

    SEC Form 4 filed by Director Levinson Sam

    4 - Clipper Realty Inc. (0001649096) (Issuer)

    2/26/26 6:40:16 PM ET
    $CLPR
    Real Estate Investment Trusts
    Real Estate

    $SYPR
    $TG
    $TITN
    $TLS
    Leadership Updates

    Live Leadership Updates

    View All

    Playboy Appoints David Miller as President, Media & Brand

    Media Veteran Miller to Oversee Global Licensing, Digital and Platform Growth Senior Appointment Reflects Playboy's Accelerating Growth Strategy and Expanding Media and Licensing Operations LOS ANGELES, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Playboy, Inc. (NASDAQ:PLBY) ("Playboy" or the "Company"), a global pleasure and leisure company, has announced that David Miller has been appointed President, Media & Brand, to drive the next phase of the Company's growth. Miller joins Playboy from The Walt Disney Company, where he served as Executive Vice President and General Manager of National Geographic Media, with full P&L responsibility across global editorial, digital, print, and social operation

    2/26/26 8:31:00 AM ET
    $PLBY
    Other Specialty Stores
    Consumer Discretionary

    Bonnell Aluminum Announces New Vice President of Sales and Marketing

    Bonnell Aluminum, a subsidiary of Tredegar Corporation (NYSE:TG), is pleased to announce the appointment of Tracy Bridges to the position of Vice President of Sales and Marketing, effective March 1, 2026. She will be replacing Eric Yost, who will be retiring from the Company after 28 years of service. Ms. Bridges has been with Bonnell Aluminum for more than 20 years, serving most recently as Director of Customer Experience. Her previous roles in the organization have included Regional Sales Manager, Segment Sales Manager, and Market Manager. Brook Hamilton, President of Bonnell Aluminum, said, "We thought it was very important to identify a successor who will give our business and custo

    2/25/26 8:30:00 AM ET
    $TG
    Metal Fabrications
    Industrials

    Designer Brands Inc. Appoints Sheamus Toal as Chief Financial Officer

    Appointment Effective February 16, 2026 COLUMBUS, Ohio, Feb. 11, 2026 /PRNewswire/ -- Designer Brands Inc. (NYSE:DBI) (the "Company," "we," "us," "our," and "Designer Brands"), today announced that Sheamus Toal will join the company as Executive Vice President, Chief Financial Officer and Principal Financial Officer, effective February 16, 2026. Mark Haley, who has served as Interim Principal Financial Officer during the transition period, will return full time to his position as Senior Vice President, Controller and Principal Accounting Officer. Sheamus brings deep financial

    2/11/26 6:45:00 AM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $SYPR
    $TG
    $TITN
    $TLS
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Montauk Renewables Schedules Full Year 2025 Conference Call for Thursday, March 12, 2026, at 8:30 a.m. ET

    PITTSBURGH, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas ("RNG"), will host a conference call and webcast on Thursday, March 12, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the full year ended December 31, 2025. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the day prior to the conference call and webcast. Full Year 2025 Conference Call and Webcast Details  Date:Thursday, March 12, 2026Time:8:30 a.m. ETPartici

    2/26/26 4:30:00 PM ET
    $MNTK
    Natural Gas Distribution
    Utilities

    WM Technology, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results via Webcast

    WM Technology, Inc. ("WM Technology" or the "Company") (NASDAQ:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced it will report financial results for its fourth quarter and full year ended December 31, 2025 after market close on Thursday, March 12, 2026. Management will host a webcast to discuss the Company's financial results at 2 p.m. Pacific Time (or 5 p.m. Eastern Time) on the same day. A replay of the call will be available at ir.weedmaps.com by the end of the day March 13. WM Technology Fourth Quarter and Full Year 2025 Financial Results Webcast   When Thursday, March 12, 2026 Time 2 p.m. PT / 5

    2/26/26 4:05:00 PM ET
    $MAPS
    Computer Software: Prepackaged Software
    Technology

    $SYPR
    $TG
    $TITN
    $TLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by ATI Physical Therapy Inc.

    SC 13D/A - ATI Physical Therapy, Inc. (0001815849) (Subject)

    12/17/24 5:51:04 PM ET
    $ATIP
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care